Anthropic’s forthcoming IPO prospectus will formally list negative public sentiment toward AI and its data centers as a material business risk, according to people familiar with the draft who spoke to CNBC. The Claude maker has already submitted a confidential Form S-1 to the SEC, and Bloomberg reports it could file publicly as soon as the end of August 2026, chasing a valuation near $2 trillion.

That framing is what makes this listing analytically interesting. Companies routinely bury “regulatory environment” boilerplate in their risk sections. Anthropic is telling investors the vibes themselves are a risk factor.

The numbers behind the disclosure make the caution rational. A Gallup survey published in May found roughly 7 in 10 Americans opposed the construction of AI data centers in their area, with close to half describing themselves as strongly opposed. With less than 3 months to the midterms, politicians in both parties are picking up the cudgel. An IPO priced against that backdrop needs to preempt the argument, not deny it.

Anthropic can afford honesty because the growth line is doing the persuading. The company just topped a $65 billion annual revenue run rate, with preliminary Q2 2026 revenue of $11.5 billion against $787 million a year earlier. The 2025 net loss came in around $42 billion, roughly a fivefold deterioration on the prior year, which is the shape of a company that has decided compute is the only moat that matters.

The syndicate reflects the ambition. Morgan Stanley, Goldman Sachs and JPMorgan Chase are being joined by Citigroup, and Bloomberg reports the structure is likely to include super-voting shares preserving control for CEO Dario Amodei, who holds roughly 2%, and his co-founders. The size target is SpaceX-scale: SpaceX’s record listing raised $75 billion at the outset and $86.2 billion including the overallotment.

The contrast with that filing is the tell. SpaceX addressed Grok’s reputational risk narrowly, as a product problem. Anthropic is conceding that the public may simply hate the category it operates in. It’s the first frontier lab to write that down for the SEC, and once one prospectus says it, the rest will have to.

Sources